This event is put on by the International Association for the Study of Lung Cancer
The IASLC 2023 Targeted Therapies of Lung Cancer Meeting is a dynamic meeting with a long tradition.?Meeting presenters will summarize the data on relevant targets for new therapies and share data on preclinical and early clinical data for each of the drugs directed against these targets.
The robust program will be live-streamed and available on-demand to thoracic oncology professionals from around the world. Presentations will summarize information about ongoing clinical trials of the newest therapies for lung cancer including data on preclinical and early clinical data.